Filippo Riva
Director Ejecutivo en Humabs BioMed SA .
Cargos activos de Filippo Riva
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Humabs BioMed SA
 Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Director Ejecutivo | 01/09/2015 | - |
| Director Financiero/CFO | 01/04/2014 | 01/08/2017 |
Historial de carrera de Filippo Riva
Antiguos cargos conocidos de Filippo Riva.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Bmob Sagl | Director Financiero/CFO | - | - |
| Fundador | - | - | |
Telormedix SA
 Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland. | Director Financiero/CFO | - | - |
Formación de Filippo Riva.
| Warwick Business School | Masters Business Admin |
| School of Economics & Business Administration | Undergraduate Degree |
Estadísticas
Internacional
| Suiza | 5 |
| Reino Unido | 2 |
Operativa
| Director of Finance/CFO | 3 |
| Founder | 1 |
| Masters Business Admin | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Telormedix SA
Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland. | Health Technology |
| Bmob Sagl | |
Humabs BioMed SA
Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Commercial Services |
- Bolsa de valores
- Insiders
- Filippo Riva
- Experiencia
